http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106749147-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-58 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-58 |
| filingDate | 2016-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106749147-B |
| titleOfInvention | Hypoglycemics and preparation method thereof, purposes |
| abstract | The present invention relates to pharmaceutical technology fields, it is related to extracting new natural drug isolated, with function of blood sugar reduction from the dark green Aglaia odorata Aglaia abbreviata C.Y.Wu blade of China, which is Bibenzyl compound bibenzyl Aglaia odorata element B (aglaiabbrevin B).External PTP1B inhibit experiments have shown that, the compound for protein tyrosine esterase 1B (PTP1B) has certain inhibitory activity, therefore it can be made into pharmaceutical preparation as PTP1B inhibitor, for treating diabetes, obesity and its complication, the health food for being beneficial to diabetic or obese patient can also be manufactured. |
| priorityDate | 2016-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 132.